GLP-1

Entity category: technology

Artificial Intelligence

Unlock Longevity: How Data Slows Aging

By 2026, precision medical forecasting will use AI and vast datasets to predict individual risks for major age-related diseases like…

Read More »
Business

Study: No Safe Exit for Some on GLP-1 Drugs

GLP-1 weight-loss medications lack a clear, evidence-based strategy for safe discontinuation, with patients often experiencing rapid reversal of health gains…

Read More »
Business

Ex-X CEO Linda Yaccarino Takes Helm at Health Tech Firm eMed

Linda Yaccarino, former CEO of X, has joined eMed Population Health as a leader, bringing her expertise in strategic partnerships…

Read More »